News Releases

July 2019

July 16, 2019 7/16/2019 First iPSC-Derived CAR T-Cell Therapy Created by Kyoto University CiRA and Takeda Collaboration Enters Process Development Toward Clinical Testing

July 10, 2019 7/10/2019 Takeda Continues Ongoing Inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index

July 8, 2019 7/8/2019 Takeda Unveil New Data from the PROPEL Study at ISTH 2019, Reinforcing the Potential Benefit for Personalized Prophylaxis with ADYNOVATE in Severe Hemophilia A

July 2, 2019 7/2/2019 Takeda Announces Baxalta’s Successful Consent Solicitation with Respect to Baxalta’s 3.600% Senior Notes due 2022, 4.000% Senior Notes due 2025, 5.250% Senior Notes due 2045

June 2019

June 30, 2019 6/30/2019 Takeda Completes Sale of XIIDRA® to Novartis

June 28, 2019 6/28/2019 Takeda Announces New Assignments of Directors

June 27, 2019 6/27/2019 Takeda Announces the Publication of its Annual Report on Form 20-F for FY2018

June 26, 2019 6/26/2019 Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR)

June 25, 2019 6/25/2019 Takeda Announces Baxalta’s Commencement of Consent Solicitation with Respect to Baxalta’s 3.600% Senior Notes due 2022, 4.000% Senior Notes due 2025, 5.250% Senior Notes due 2045

・For legacy Shire information, click here